Literature DB >> 19028890

Function and regulation of class I ribonucleotide reductase-encoding genes in mycobacteria.

Mohube B Mowa1, Digby F Warner, Gilla Kaplan, Bavesh D Kana, Valerie Mizrahi.   

Abstract

Ribonucleotide reductases (RNRs) are crucial to all living cells, since they provide deoxyribonucleotides (dNTPs) for DNA synthesis and repair. In Mycobacterium tuberculosis, a class Ib RNR comprising nrdE- and nrdF2-encoded subunits is essential for growth in vitro. Interestingly, the genome of this obligate human pathogen also contains the nrdF1 (Rv1981c) and nrdB (Rv0233) genes, encoding an alternate class Ib RNR small (R2) subunit and a putative class Ic RNR R2 subunit, respectively. However, the role(s) of these subunits in dNTP provision during M. tuberculosis pathogenesis is unknown. In this study, we demonstrate that nrdF1 and nrdB are dispensable for the growth and survival of M. tuberculosis after exposure to various stresses in vitro and, further, that neither gene is required for growth and survival in mice. These observations argue against a specialist role for the alternate R2 subunits under the conditions tested. Through the construction of nrdR-deficient mutants of M. tuberculosis and Mycobacterium smegmatis, we establish that the genes encoding the essential class Ib RNR subunits are specifically regulated by an NrdR-type repressor. Moreover, a strain of M. smegmatis mc(2)155 lacking the 56-kb chromosomal region, which includes duplicates of nrdHIE and nrdF2, and a mutant retaining only one copy of nrdF2 are shown to be hypersensitive to the class I RNR inhibitor hydroxyurea as a result of depleted levels of the target. Together, our observations identify a potential vulnerability in dNTP provision in mycobacteria and thereby offer a compelling rationale for pursuing the class Ib RNR as a target for drug discovery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19028890      PMCID: PMC2632068          DOI: 10.1128/JB.01409-08

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  70 in total

1.  Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement.

Authors:  T Parish; N G Stoker
Journal:  Microbiology       Date:  2000-08       Impact factor: 2.777

2.  Identification of a bacterial regulatory system for ribonucleotide reductases by phylogenetic profiling.

Authors:  Dmitry A Rodionov; Mikhail S Gelfand
Journal:  Trends Genet       Date:  2005-07       Impact factor: 11.639

Review 3.  Proficient and accurate bypass of persistent DNA lesions by DinB DNA polymerases.

Authors:  Daniel F Jarosz; Veronica G Godoy; Graham C Walker
Journal:  Cell Cycle       Date:  2007-04-23       Impact factor: 4.534

4.  Constitutively high dNTP concentration inhibits cell cycle progression and the DNA damage checkpoint in yeast Saccharomyces cerevisiae.

Authors:  Andrei Chabes; Bruce Stillman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

5.  Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells.

Authors:  Pelle Håkansson; Anders Hofer; Lars Thelander
Journal:  J Biol Chem       Date:  2006-01-24       Impact factor: 5.157

6.  Antibiotic resistance gene cassettes derived from the omega interposon for use in E. coli and Streptomyces.

Authors:  M H Blondelet-Rouault; J Weiser; A Lebrihi; P Branny; J L Pernodet
Journal:  Gene       Date:  1997-05-06       Impact factor: 3.688

Review 7.  The enzyme ribonucleotide reductase: target for antitumor and anti-HIV therapy.

Authors:  T Szekeres; M Fritzer-Szekeres; H L Elford
Journal:  Crit Rev Clin Lab Sci       Date:  1997       Impact factor: 6.250

8.  Reactive nitrogen intermediates have a bacteriostatic effect on Mycobacterium tuberculosis in vitro.

Authors:  Marcia A Firmani; Lee W Riley
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations.

Authors:  B K Choy; G A McClarty; A K Chan; L Thelander; J A Wright
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

10.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

View more
  20 in total

1.  Functional analysis of molybdopterin biosynthesis in mycobacteria identifies a fused molybdopterin synthase in Mycobacterium tuberculosis.

Authors:  Monique J Williams; Bavesh D Kana; Valerie Mizrahi
Journal:  J Bacteriol       Date:  2010-10-22       Impact factor: 3.490

2.  CT406 encodes a chlamydial ortholog of NrdR, a repressor of ribonucleotide reductase.

Authors:  Elizabeth Di Russo Case; Johnny C Akers; Ming Tan
Journal:  J Bacteriol       Date:  2011-07-01       Impact factor: 3.490

Review 3.  Protein targets for structure-based anti-Mycobacterium tuberculosis drug discovery.

Authors:  Zhiyong Lou; Xiaoxue Zhang
Journal:  Protein Cell       Date:  2010-06-04       Impact factor: 14.870

Review 4.  Class I ribonucleotide reductases: metallocofactor assembly and repair in vitro and in vivo.

Authors:  Joseph A Cotruvo; Joanne Stubbe
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

5.  Role of the DinB homologs Rv1537 and Rv3056 in Mycobacterium tuberculosis.

Authors:  Bavesh D Kana; Garth L Abrahams; Nackmoon Sung; Digby F Warner; Bhavna G Gordhan; Edith E Machowski; Liana Tsenova; James C Sacchettini; Neil G Stoker; Gilla Kaplan; Valerie Mizrahi
Journal:  J Bacteriol       Date:  2010-02-05       Impact factor: 3.490

6.  The class Ib ribonucleotide reductase from Mycobacterium tuberculosis has two active R2F subunits.

Authors:  Marta Hammerstad; Asmund K Røhr; Niels H Andersen; Astrid Gräslund; Martin Högbom; K Kristoffer Andersson
Journal:  J Biol Inorg Chem       Date:  2014-03-02       Impact factor: 3.358

7.  Quantitative proteomic reveals gallium maltolate induces an iron-limited stress response and reduced quorum-sensing in Pseudomonas aeruginosa.

Authors:  Magdalena Piatek; Darren M Griffith; Kevin Kavanagh
Journal:  J Biol Inorg Chem       Date:  2020-10-30       Impact factor: 3.358

8.  Ribonucleotide reductase metallocofactor: assembly, maintenance and inhibition.

Authors:  Caiguo Zhang; Guoqi Liu; Mingxia Huang
Journal:  Front Biol (Beijing)       Date:  2014-01-02

9.  NrdH-redoxin of Mycobacterium tuberculosis and Corynebacterium glutamicum dimerizes at high protein concentration and exclusively receives electrons from thioredoxin reductase.

Authors:  Koen Van Laer; Aleksandra M Dziewulska; Marcus Fislage; Khadija Wahni; Abderahim Hbeddou; Jean-Francois Collet; Wim Versées; Luis M Mateos; Veronica Tamu Dufe; Joris Messens
Journal:  J Biol Chem       Date:  2013-01-28       Impact factor: 5.157

10.  A DinB Ortholog Enables Mycobacterial Growth under dTTP-Limiting Conditions Induced by the Expression of a Mycobacteriophage-Derived Ribonucleotide Reductase Gene.

Authors:  Shreya Ghosh; Sourabh Samaddar; Prithwiraj Kirtania; Sujoy K Das Gupta
Journal:  J Bacteriol       Date:  2015-11-02       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.